Locametz
Payments companies reported to CMS as associated with Locametz. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Locametz, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Locametz
These are the largest totals companies reported as associated with Locametz. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Ephraim Parent | Jacksonville, FL | Nuclear Medicine | $137.48 |
| Luke Nordquist | Omaha, NE | Hematology & Oncology | $86.70 |
| Frankis Almaguel | San Bernardino, CA | $68.61 | |
| Ernie Meth | Murrieta, CA | Nuclear Medicine | $68.61 |
| Michael Wertheim | Fort Myers, FL | Hematology & Oncology | $45.94 |
| Ryon Nakasone | Honolulu, HI | Hematology & Oncology | $45.52 |
| Omar Ortiz-Alvarado | Coral Springs, FL | Urology | $37.53 |
| Aaron Brafman | Coral Springs, FL | Urology | $37.53 |
| Blake Evans | Coral Springs, FL | Urology | $37.53 |
| Dawn Scarzella | Coral Springs, FL | Urology | $37.53 |
Prescribed Locametz?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.